ArticleParasites & vectors2026
Differences in metaviromes between Aedes aegypti and Aedes albopictus from sympatric areas on Hainan Island and the Leizhou Peninsula, China.
Article in Parasites & vectors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundAedes aegypti and Ae. albopictus are the most important vector mosquito species globally and are capable of transmitting various viral diseases, such as dengue fever, zika virus disease, and chikungunya fever. Although they overlap in terms of ecological niches and geographical distribution, their virus carriage and transmission capacities differ significantly. Metavirome studies can provide new perspectives for understanding these differences.
methodsIn this study, next-generation sequencing (NGS) was used to analyze the epidemiologically significant metaviromes of Ae. aegypti and Ae. albopictus on Hainan Island and the Leizhou Peninsula, China. A bioinformatics analysis pipeline was used to compare the viral compositions of the two mosquito species.
resultsIn the sympatric areas, 250 viral species from 60 families were annotated to Ae. aegypti at the read level, whereas 406 vial species from 66 families were annotated to Ae. albopictus at the read level, revealing significant differences in the metaviromes of the two mosquito species. Notably, Ae. albopictus exhibited significantly greater viral diversity than Ae. aegypti (p < 0.05). The 50 viruses with the greatest abundance in two mosquito species were selected for data analysis, revealing 64% viral similarity, with 32 common viruses and 18 distinct viruses between the two species, although the relative abundances of each virus differed notably. Phasi Charoen-like Phasivirus (PCLV) from Phenuiviridae showed the highest relative abundance in all Ae. aegypti sample pools, whereas Orthophasmavirus barstukasense (Phasmaviridae), Gihfavirus pelohabitans (Steitzviridae), and unclassified Wenzhou sobemo-like virus 4 (WSLV4) predominated in different Ae. albopictus sample pools.
conclusionsThe metavirome compositions of Ae. aegypti and Ae. albopictus in the sympatric areas of Hainan Island and the Leizhou Peninsula differed significantly. The viral diversity of Ae. albopictus was significantly higher than that of Ae. aegypti, and notable differences in viral composition and abundance were observed between the two species. However, the 50 most abundant viruses detected in both mosquito species also exhibited a degree of similarity. These findings support further research into the viral compositions of these two Aedes species. Moreover, analyzing these distinct viral compositions aids understanding of the vector capacity and vector competence of these mosquitoes, which will provide theoretical support for vector control efforts on Hainan Island and the Leizhou Peninsula.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.